Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
EPIC: NVN
Market: TSX
52-week High/Low:
Sector: Pharma & Biotech
Market Cap: 0.00M
NVENTA BIOPHARMA CORP

NVENTA BIOPHARMA CORP

A biopharmaceutical company, focuses on the discovery, development and commercialization of innovative therapeutic vaccines for the treatment of infectious diseases and cancer, with a focus on diseases caused by the human papillomavirus (HPV).

Deal NVN Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.

NVENTA BIOPHARMA CORP

www.nventacorp.com

Interactive graph

col 3
col 4
col 5
col 6

NVENTA BIOPHARMA CORP RNS announcements

Sorry, there are no rns announcements by this company.

© Proactive Investors 2015